TracyWilliamDobbsMD

Oncology • Knoxville, TN

Physician

Join to view full profile

Dr. Dobbs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dobbs' full profile

Already have an account?

Office
1415 Old Weisgarber Rd
Suite 200
Knoxville, TN 37909
Phone+1 865-934-5800

Fax+1 865-934-5801
Is this information wrong?

Education & Training

University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1983 - 1986
University of Missouri Kansas City School of MedicineClass of 1983

Certifications & Licensure

TN State Medical License 1989 - 2025
KY State Medical License 1993 - 2025
OK State Medical License 1984 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Start of enrollment: 2007 Dec 01
Active, not recruiting
Phase 3
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Completed
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin Start of enrollment: 2011 Jan 16
Completed
Phase 3
Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
Terminated
Phase 3
TR(ACE) Assay Clinical Specimen Study Start of enrollment: 2016 Sep 01
Unknown status
Join now to see all

Publications & Presentations

PubMed

4 citations
Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer
Heinz-Josef Lenz, Philip A. Philip, Mark N. K. Saunders, Tatjana Kolevska, Kalyan Kusum Mukherjee, Leslie Samuel, Shailesh Bondarde, T. Dobbs, Mary Tagliaferri, Ute Ho...> ;Cancer Chemotherapy and Pharmacology. 2017 Oct 17
17 citations
A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carbo...
Anshu K. Jain, Randall S. Hughes, Alan B. Sandler, Afshin Dowlati, Lee S. Schwartzberg, Tracy Dobbs, Larry Schlabach, Jean Wu, Nancy J. Muldowney, Hak Choy> ;Journal of Thoracic Oncology. 2009 Jun 1
A phase II study of concurrent chemoradiotherapy with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and ca...
Hughes RS, Sandler AB, Jain AK, Dowlati A, Schwartzberg LS, Dobbs T, Schlabach L, Wu J, Muldowney NJ, Choy H> ;J. Clin. Oncol.. 2008-05-20
Weekly docetaxel and irinotecan for patients with advanced non-small cell lung cancer (NSCLC): Results of a multi-center, phase II study.
Ramalingam S, Dobbs TW, Coke DE, Wojtowicz-Praga S, Belani CP> ;J. Clin. Oncol.. 2004-07-15
17 citations
Phase II Trial of Subcutaneous Interleukin-2, Subcutaneous Interferon-α, Intravenous Combination Chemotherapy, and Oral Tamoxifen in the Treatment of Metastatic Melano...
Robert O. Dillman, Gamini Soori, Michael C. Wiemann, Richard S. Schulof, Tracy W. Dobbs, Richard H. Ruben, Carol DePriest, C. Church> ;Cancer Biotherapy & Radiopharmaceuticals. 2000 Oct 1
Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
Belani CP, Einzig A, Bonomi P, Dobbs T, Capozzoli MJ, Earhart R, Cohen LJ, Luketich JD> ;Ann. Oncol.. 2000-06-01
2 citations
Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study.
Gamini Soori, Robert K. Oldham, Tracy W. Dobbs, Martin J. Bury, C. Church, Carol DePriest> ;Cancer Biotherapy & Radiopharmaceuticals. 2000 Apr 1
A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC).
Socinski, M. A., Saleh, M. N., Trent, D. F., Dobbs, T. W., Zehngebot, L. M., Levine, M. A., Bordoni, R., Stella, P. J.> ;Ann Oncol. 2009 Jun 01
Docetaxel and cisplatin in patients with advanced non small-cell lung cancer (NSCLC): a multicenter phase II trial.
Belani, C. P., Bonomi, P., Dobbs, T. W., DeVore, R. F., Ettinger, D. S., Jett, J., Luketich, J. D., Cohen, L. J., Johnson, D. H.> ;Clin Lung Cancer. 1999 Nov
Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study.
Ramalingam, S., Dobbs, T. W., Einzig, A. I., Wojtowicz-Praga, S., Cascino, M., Bonomi, P., Belani, C. P.> ;Cancer Chemother Pharmacol. 2004 May
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Turkey Creek Medical CenterKnoxville, Tennessee
Greeneville Community Hospital EastGreeneville, Tennessee
Morristown-Hamblen Healthcare SystemMorristown, Tennessee
Lakeway Regional HospitalMorristown, Tennessee
Fort Sanders Regional Medical CenterKnoxville, Tennessee
Sweetwater HospitalSweetwater, Tennessee
Tennova Physicians Regional Medical CenterKnoxville, Tennessee